A61K 2039/6006
Cells
Official title: {Cells}
A61K2039/6006 (Cells) appears on 89 US grants and 150 published applications in this corpus.
Search patents in A61K- Granted patents
- 89
- Published applications
- 150
- Assignees
- 111
- Inventors
- 321
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 1 | 1 |
| 2006 | 1 | 3 |
| 2007 | 1 | 4 |
| 2008 | 0 | 3 |
| 2009 | 1 | 1 |
| 2010 | 1 | 5 |
| 2011 | 1 | 7 |
| 2012 | 0 | 2 |
| 2013 | 4 | 2 |
| 2014 | 4 | 9 |
| 2015 | 4 | 8 |
| 2016 | 3 | 7 |
| 2017 | 5 | 8 |
| 2018 | 9 | 14 |
| 2019 | 8 | 8 |
| 2020 | 9 | 8 |
| 2021 | 5 | 12 |
| 2022 | 6 | 10 |
| 2023 | 3 | 11 |
| 2024 | 7 | 10 |
| 2025 | 7 | 5 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for preventing and treating virus infection15 Sep 2026US 12,734,234 B2University of Virginia Patent Foundation
- Smallpox vaccine for cancer treatment26 May 2026US 12,636,361 B2Calidi Biotherapeutics (Nevada), Inc.
- Vaccines for in vivo expression of nucleic acids and methods of using the same28 Oct 2025US 12,453,768 B2Orbis Health Solutions LLC
- Vaccination using herpesvirus genomes in nucleic acid form14 Oct 2025US 12,440,554 B2The Regents of the University of California
- Silicified cell replicas, methods of making, and methods of using7 Oct 2025US 12,433,940 B2UNM Rainforest Innovations
- Bacterial type iv secretion systems, methods of use for in vivo dna delivery, and method of engineering8 Oct 2026US 2026/0308604 A1University of Kentucky Research Foundation
- Extracellular vesicles targeting dendritic cells and uses thereof30 Jul 2026US 2026/0216367 A1Lonza Sales AG
- Silicified cell replicas, methods of making, and methods of using23 Jul 2026US 2026/0207723 A1UNM Rainforest Innovations
- Methods and compositions for vaccinating piglets against prrs-1 virus9 Jul 2026US 2026/0191945 A1Zoetis Services LLC
- Treatment and/or prevention of an infection by mono/divalent and polyvalent antigen particle-mediated immune responses30 Apr 2026US 2026/0115276 A1UniversitäT Ulm
Most cited
By later US patents
- Oral vaccine comprising antigen surface-associated with red blood cells44US 5,643,577 AThe University of Newcastle Research Associates Limited · 1997
- Carrier-bound immunogenic determinants and carrier therefor36US 4,894,229 ASouth African Inventions Development Corporation · 1990
- Compositions and methods of enhancing immune responses35US 8,604,178 B2Board of Trustees of the University of Arkansas · 2013
- Compositions and methods for the treatment or prevention of hepatitis B virus infection21US 8,722,054 B2GlobeImmune, Inc. · 2014
- Compositions and methods of enhancing immune responses18US 9,226,957 B2Board of Trustees of the University of Arkansas · 2016